Akari Therapeutics PLC (AKTX)
1.66
+0.21
(+14.48%)
USD |
NASDAQ |
May 09, 16:00
1.66
0.00 (0.00%)
After-Hours: 20:00
Akari Therapeutics Cash from Operations (TTM)
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
DBV Technologies SA | -79.65M |
Cellectis SA | -24.75M |
Adaptimmune Therapeutics PLC | -140.88M |
Biodexa Pharmaceuticals Plc | -8.515M |
NuCana PLC | -32.90M |